{"slideshow_credits": null, "snippet": "Nestl\u00e9 Health Science is investing $65 million in Seres Health, a start-up focused on restoring the \u201cmicrobiome,\u201d the host of microorganisms that provide vital functions for humans.", "abstract": "Nestl\u00e9 Health Science is investing $65 million in Seres Health, a start-up focused on restoring the \u201cmicrobiome,\u201d the host of microorganisms that provide vital functions for humans.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2015/01/06/nestle-health-sciences-to-invest-65-million-in-a-boston-biotech-start-up/", "lead_paragraph": null, "headline": {"main": "Nestl\u00e9 Health Science to Invest $65 Million in a Biotech Start-Up", "kicker": "DealBook"}, "_id": "54abced038f0d83eda14cdc5", "word_count": "512", "multimedia": [], "pub_date": "2015-01-06T07:00:17Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Nestle SA", "name": "organizations", "rank": "1"}, {"value": "Biotechnology and Bioengineering", "name": "subject", "rank": "1"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "2"}, {"value": "Microbiology", "name": "subject", "rank": "3"}, {"value": "Start-ups", "name": "subject", "rank": "4"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}